These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17241877)

  • 41. Hepatotoxicity to several nonsteroidal anti-inflammatory drugs with diclofenac induced histological changes.
    Adebajo AO; Eastmond CJ
    Clin Rheumatol; 1992 Mar; 11(1):120-1. PubMed ID: 1582111
    [No Abstract]   [Full Text] [Related]  

  • 42. Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?
    Daly AK
    Pharm Res; 2017 Aug; 34(8):1564-1569. PubMed ID: 28028769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
    Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using genome-wide association studies to identify genes important in serious adverse drug reactions.
    Daly AK
    Annu Rev Pharmacol Toxicol; 2012; 52():21-35. PubMed ID: 21819236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of ABCC3-1767G/A polymorphism among patients with antiretroviral-associated hepatotoxicity.
    Singh H; Lata S; Choudhari R; Dhole TN
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1124. PubMed ID: 32212330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
    Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
    Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of phenobarbital on metabolism and toxicity of diclofenac sodium in rat hepatocytes in vitro.
    Wang AG; Xia T; Yuan J; Yu RA; Yang KD; Chen XM; Qu W; Waalkes MP
    Food Chem Toxicol; 2004 Oct; 42(10):1647-53. PubMed ID: 15304311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity.
    Boelsterli UA
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):307-22. PubMed ID: 14575648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
    Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
    Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonsteroidal anti-inflammatory drug-induced hepatoxicity.
    Unzueta A; Vargas HE
    Clin Liver Dis; 2013 Nov; 17(4):643-56, ix. PubMed ID: 24099022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
    Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
    Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids.
    Kirchheiner J; Meineke I; Fuhr U; Rodríguez-Antona C; Lebedeva E; Brockmöller J
    Pharmacogenomics; 2008 Mar; 9(3):277-88. PubMed ID: 18303964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.
    Huang YS; Chern HD; Su WJ; Wu JC; Chang SC; Chiang CH; Chang FY; Lee SD
    Hepatology; 2003 Apr; 37(4):924-30. PubMed ID: 12668988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.
    Huang YS; Su WJ; Huang YH; Chen CY; Chang FY; Lin HC; Lee SD
    J Hepatol; 2007 Jul; 47(1):128-34. PubMed ID: 17400324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy.
    Sookoian S; Castaño G; Burgueño A; Gianotti TF; Pirola CJ
    J Hepatol; 2008 Jan; 48(1):125-32. PubMed ID: 17997497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.
    Martínez C; García-Martín E; Blanco G; Gamito FJ; Ladero JM; Agúndez JA
    Br J Clin Pharmacol; 2005 Jan; 59(1):62-9. PubMed ID: 15606441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients.
    Naesens M; Kuypers DR; Verbeke K; Vanrenterghem Y
    Transplantation; 2006 Oct; 82(8):1074-84. PubMed ID: 17060857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between structural alerts in NSAIDs and idiosyncratic hepatotoxicity: an analysis of spontaneous report data from the WHO database.
    Jessurun N; van Puijenbroek E
    Drug Saf; 2015 May; 38(5):511-5. PubMed ID: 25787329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide.
    Niemi M; Leathart JB; Neuvonen M; Backman JT; Daly AK; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Oct; 74(4):380-7. PubMed ID: 14534525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.